Core Viewpoint - Duople's customized linear phased array probe for linear friction welding blade detection addresses the challenges in detecting engine fan blade linear friction welds in the aerospace sector [2] Group 1 - The company has developed a specialized tool for the aerospace industry [2] - The linear phased array probe is designed for detecting linear friction welding in engine fan blades [2] - This innovation resolves significant detection difficulties in the manufacturing process [2]

格隆汇11月17日丨多浦乐(301528.SZ)在投资者互动平台表示，公司产品主要以超声无损检测为主。 ...

Group 1 - Duopule plans to reduce its shareholding by no more than 1%, amounting to a maximum of 619,000 shares [1] - Lideman intends to acquire 70% of Xiansheng Xiangrui for 1.733 billion yuan, focusing on tuberculosis screening and diagnosis [2] - Huahuan Group is planning a change in control, leading to a temporary suspension of its stock [3] Group 2 - Dongbai Group clarifies it does not engage in duty-free business, maintaining normal operations [4][5] - Changsheng Bearing's actual controller plans to reduce holdings by up to 1.99%, equating to 5.94 million shares [6][7] - Jidian plans to invest 5.698 billion yuan in the Baicheng Phase II coal power project, a key initiative under the national "14th Five-Year Plan" [9][10] Group 3 - Baoneng New Energy reports completion of land-based works for the expansion of the Lufeng Qiaohai Bay Power Plant [11][12] - Changshu Bank proposes to appoint Lu Dingchang as the new president and chief compliance officer [13][14] - Kangqiang Electronics plans to reduce its shareholding by no more than 1%, totaling up to 3.7526 million shares [14] Group 4 - Jilin Chemical Fiber intends to reduce its holdings by up to 2%, equating to 49.1774 million shares [15][16] - CanSino's inhaled tuberculosis vaccine has commenced Phase I clinical trials in Indonesia [17][18] - ST Dongyi's stock has been suspended for review due to significant price fluctuations [19] Group 5 - ST Yatai plans to reduce its holdings by up to 1.98%, totaling 6.4 million shares [20] - Huaren Pharmaceutical intends to reduce its holdings by up to 3%, equating to 35.4663 million shares [21] - Jianglong Shipbuilding's controlling shareholder plans to reduce holdings by up to 2%, amounting to 7.5534 million shares [22] Group 6 - Borui Pharmaceutical's BGM1812 injection has received approval for clinical trials targeting overweight or obesity [23][24] - ST Zhongzhu announces the transfer of 10.38% of its shares, totaling approximately 403 million yuan [25][26] - Shenzhou Digital plans to establish an employee stock ownership plan with a maximum fundraising of 360 million yuan [27][28] Group 7 - Kaichuang Electric plans to establish a joint research center with Tsinghua University, focusing on embodied intelligence [29] - Daming City intends to acquire 19.43% of Baicaibang for 694 million yuan, specializing in communication solutions [29]

Core Points - Duople's shareholder Cai Shuping plans to reduce his stake by up to 619,000 shares, representing no more than 1% of the total share capital, due to personal financial needs [1] - As of the announcement date, Cai Shuping holds 4,060,560 shares, accounting for 6.56% of Duople's total share capital [1] - Duople was listed on the Shenzhen Stock Exchange's ChiNext board on August 28, 2023, with an initial issuance of 15.5 million shares at a price of 71.80 yuan per share [1] - The stock reached a peak price of 185 yuan on its first trading day but has since experienced a decline, currently trading below its initial offering price [1] - The total funds raised from the IPO amounted to 1.1129 billion yuan, with a net amount of 1.0079 billion yuan after deducting issuance costs [1] - The final net fundraising amount exceeded the original plan by 518.65 million yuan [1] - The funds are intended for the construction of a non-destructive testing intelligent production base, headquarters building, and R&D center [1][2]

Core Viewpoint - Duople (301528) announced the appointment of Liu Junke as the representative for securities affairs on the evening of November 13 [1] Group 1 - The company has made a significant personnel change by hiring Liu Junke for the role of securities affairs representative [1]

Core Viewpoint - The announcement from Duoplele indicates that shareholder Cai Shuping plans to reduce his stake in the company by selling up to 619,000 shares, which represents 1% of the total share capital [2] Group 1: Shareholder Actions - Cai Shuping holds 4,060,560 shares, accounting for 6.56% of the company's total share capital [2] - The planned reduction will occur within three months after a 15 trading day period following the announcement [2] - The shares will be sold through a centralized bidding method [2]

Core Viewpoint - Duoplele announced the convening of its first employee representative assembly for 2025 on November 13, 2025, where Liu Xiaohong was elected as the employee representative director of the company's third board of directors [2] Group 1 - The employee representative assembly is scheduled for November 13, 2025 [2] - Liu Xiaohong has been elected as the employee representative director [2]

Group 1 - The core point of the article is that Duople (SZ 301528) announced a plan for a major shareholder, Mr. Cai Shuping, to reduce his stake in the company by selling up to approximately 620,000 shares within three months after a 15 trading day period from the announcement date [1] - Mr. Cai Shuping currently holds about 4.06 million shares, which represents 6.56% of the total share capital of Duople [1] - Duople's market capitalization is reported to be 4 billion yuan [1] Group 2 - For the year 2024, Duople's revenue composition is entirely from the non-destructive testing industry, accounting for 100% [1]

Core Viewpoint - Duople (301528.SZ) announced that shareholder Mr. Cai Shuping plans to reduce his holdings by up to 619,000 shares, which represents no more than 1% of the company's total share capital, within three months after 15 trading days from the announcement date [1] Summary by Relevant Sections - Shareholder Action - Mr. Cai Shuping intends to reduce his stake in the company through centralized bidding [1] - The planned reduction is capped at 619,000 shares, equating to 1% of the total share capital [1]

Core Viewpoint - Duople (301528.SZ) announced that shareholder Mr. Cai Shuping plans to reduce his holdings by up to 619,000 shares, which represents no more than 1% of the company's total share capital, within three months starting from 15 trading days after the announcement [1] Summary by Category - Shareholder Action - Mr. Cai Shuping intends to reduce his stake in the company through centralized bidding [1] - The maximum number of shares to be sold is 619,000 [1] - This reduction will account for up to 1% of the total share capital of Duople [1]